These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 28487875)
1. Impact of sertraline on serum concentration of CRP in hemodialysis patients with depression. Zahed NS; Sharifi M; Karimi M; Nikbakht H J Renal Inj Prev; 2017; 6(1):65-69. PubMed ID: 28487875 [No Abstract] [Full Text] [Related]
2. Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial. Taraz M; Khatami MR; Dashti-Khavidaki S; Akhonzadeh S; Noorbala AA; Ghaeli P; Taraz S Int Immunopharmacol; 2013 Nov; 17(3):917-23. PubMed ID: 24121064 [TBL] [Abstract][Full Text] [Related]
3. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Kalender B; Ozdemir AC; Koroglu G Nephron Clin Pract; 2006; 102(3-4):c115-21. PubMed ID: 16282695 [TBL] [Abstract][Full Text] [Related]
4. C reactive protein and depressive symptoms in hemodialysis patients: A questionable association. Chilcot J; Friedli K; Guirguis A; Wellsted D; Farrington K; Davenport A Hemodial Int; 2017 Oct; 21(4):542-548. PubMed ID: 27678345 [TBL] [Abstract][Full Text] [Related]
5. Fatigue is associated with serum interleukin-6 levels and symptoms of depression in patients on chronic hemodialysis. Bossola M; Di Stasio E; Giungi S; Rosa F; Tazza L J Pain Symptom Manage; 2015 Mar; 49(3):578-85. PubMed ID: 25135658 [TBL] [Abstract][Full Text] [Related]
6. Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Pizzi C; Mancini S; Angeloni L; Fontana F; Manzoli L; Costa GM Clin Pharmacol Ther; 2009 Nov; 86(5):527-32. PubMed ID: 19641491 [TBL] [Abstract][Full Text] [Related]
7. Relationship between a pro- and anti-inflammatory cytokine imbalance and depression in haemodialysis patients. Taraz M; Khatami MR; Gharekhani A; Abdollahi A; Khalili H; Dashti-Khavidaki S Eur Cytokine Netw; 2012; 23(4):179-86. PubMed ID: 23360798 [TBL] [Abstract][Full Text] [Related]
8. Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study. Michalakeas CA; Parissis JT; Douzenis A; Nikolaou M; Varounis C; Andreadou I; Antonellos N; Markantonis-Kiroudis S; Paraskevaidis I; Ikonomidis I; Lykouras E; Kremastinos D J Card Fail; 2011 Sep; 17(9):748-54. PubMed ID: 21872145 [TBL] [Abstract][Full Text] [Related]
9. The Plasma Neurofilament Light Chain, Brain-Derived Neurotrophic Factor, and Risk of Depression in Chronic Hemodialysis Patients. Stanisławska M; Roman M; Nowicki M Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255209 [TBL] [Abstract][Full Text] [Related]
10. Depression and serum interleukin-6 levels in patients on dialysis. Uglešić B; Ljutić D; Lasić D; Jeličić I; Višić V; Glavina T; Šundov Ž; Puljiz Ž; Cvitanović MŽ; Meter A Psychiatr Danub; 2015 Jun; 27(2):168-73. PubMed ID: 26057312 [TBL] [Abstract][Full Text] [Related]
11. Symptoms of depression and anxiety over time in chronic hemodialysis patients. Bossola M; Ciciarelli C; Di Stasio E; Conte GL; Antocicco M; Rosa F; Tazza L J Nephrol; 2012; 25(5):689-98. PubMed ID: 22009936 [TBL] [Abstract][Full Text] [Related]
12. Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline. Turner-Stokes L; Hassan N; Pierce K; Clegg F Clin Rehabil; 2002 May; 16(3):261-8. PubMed ID: 12017513 [TBL] [Abstract][Full Text] [Related]
13. Serum levels of folate and cobalamin are lower in depressed than in nondepressed hemodialysis subjects. Clement L; Boylan M; Miller VG; Rockwell M; Allred K J Ren Nutr; 2007 Sep; 17(5):343-9. PubMed ID: 17720104 [TBL] [Abstract][Full Text] [Related]
14. Serum S100B protein is associated with depressive symptoms in patients with end-stage renal disease. Kim JK; Kim SG; Kim HJ; Song YR Clin Biochem; 2012 Dec; 45(18):1573-7. PubMed ID: 22935566 [TBL] [Abstract][Full Text] [Related]
15. [Medical conditions of depression in end-stage renal disease patients treated on hemodialysis]. Ksiazek P; Makara-Studzińska M; Załuska A; Kaim R; Załuska W Przegl Lek; 2009; 66(12):1036-9. PubMed ID: 20514901 [TBL] [Abstract][Full Text] [Related]
16. Association of Depression With Selenium Deficiency and Nutritional Markers in the Patients With End-Stage Renal Disease on Hemodialysis. Ekramzadeh M; Mazloom Z; Sagheb M J Ren Nutr; 2015 Jul; 25(4):381-7. PubMed ID: 25680525 [TBL] [Abstract][Full Text] [Related]
17. Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND). Hedayati SS; Daniel DM; Cohen S; Comstock B; Cukor D; Diaz-Linhart Y; Dember LM; Dubovsky A; Greene T; Grote N; Heagerty P; Katon W; Kimmel PL; Kutner N; Linke L; Quinn D; Rue T; Trivedi MH; Unruh M; Weisbord S; Young BA; Mehrotra R Contemp Clin Trials; 2016 Mar; 47():1-11. PubMed ID: 26621218 [TBL] [Abstract][Full Text] [Related]
18. Quality of life in chronic kidney disease: effects of treatment modality, depression, malnutrition and inflammation. Kalender B; Ozdemir AC; Dervisoglu E; Ozdemir O Int J Clin Pract; 2007 Apr; 61(4):569-76. PubMed ID: 17263698 [TBL] [Abstract][Full Text] [Related]
19. A Randomized Placebo-Controlled Trial of Omega-3 and Sertraline in Depressed Patients With or at Risk for Coronary Heart Disease. Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS J Clin Psychiatry; 2019 Jun; 80(4):. PubMed ID: 31163106 [TBL] [Abstract][Full Text] [Related]